Corydaline is a natural alkaloid derivative and potent acetylcholinesterase inhibitor currently under investigation in clinical trials for the treatment of functional dyspepsia. To ensure rigorous quality… Read more
Corydaline is a natural alkaloid derivative and potent acetylcholinesterase inhibitor currently under investigation in clinical trials for the treatment of functional dyspepsia. To ensure rigorous quality control and accurate analytical testing, laboratory professionals utilize high-quality reference standards of this compound, alongside its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled analogues. These related compounds are essential tools for impurity profiling and method validation, enabling precise identification and quantification of related substances during stability studies and batch release. By incorporating these specialized standards into analytical workflows, researchers can effectively characterize the chemical profile of the parent drug, support regulatory compliance, and maintain the integrity of pharmaceutical development processes.